首页 | 本学科首页   官方微博 | 高级检索  
     

国产长春瑞滨联合顺铂治疗转移性乳腺癌的临床观察
引用本文:王燕. 国产长春瑞滨联合顺铂治疗转移性乳腺癌的临床观察[J]. 临床肿瘤学杂志, 2003, 8(4): 298-298,F003
作者姓名:王燕
作者单位:750021,银川,宁夏人民医院肿瘤内科
摘    要:目的:观察国产长春瑞滨(盖诺)联合顺铂方案治疗转移性乳腺癌的临床疗效。方法:运用盖诺(25mg/m^2 IV dl,d8)加顺铂(DDP80mg/m^32 IV d1)治疗转移性乳腺癌26例。结果:取得CR3例(11.5%),PR12例(46.1%),总有效率RR(CR PR)达57.6%。主要毒副作用为骨髓抑制,胃肠道反应和静脉炎。白细胞减少的发生率100%,其中Ⅲ-Ⅳ度达57.7%。恶心、呕吐的发生率92.3%,Ⅲ-Ⅳ度达11.5%。静脉炎的发生率15.4%。结论:国产长春瑞滨联合顺铂对转移性乳腺癌疗效确切,且毒性可以耐受,可以作为对蒽环类药物治疗后复发,转移乳腺癌患者的二线治疗方案。

关 键 词:春瑞滨 顺铂 联合治疗 转移性乳腺癌 临床观察 疗效 毒副作用
文章编号:1009-0460(2003)04-0298-02

Combination Chemotherapy With Vinorelbine and Cisplatin in the Treatment of Metastatic Breast Cancer
WANG Yan. Combination Chemotherapy With Vinorelbine and Cisplatin in the Treatment of Metastatic Breast Cancer[J]. Chinese Clinical Oncology, 2003, 8(4): 298-298,F003
Authors:WANG Yan
Affiliation:WANG Yan.Department of Oncology Ninxia Renmin Hospital,YinChuan 750021
Abstract:Objective:To evaluate the effective of combination chemotheraphy of NVB plus cisplatin on metastatic breast cancer.Methods:26 patients of metastatic breast cancer were treated with NVB 25mg/m 2 IVD for day1 and day8 and cisplatin 80mg/m 2 IV for day1.Results:Complete response was observed in 3 patients,partial response in 12 patients,with an overall response rate of 57.6%,The most common toxicities were seen myelosuppression,vomiting and phlebitis.Leukopenia was observed in all patients(100%) and grade 3 and grade 4 leukopenia in most of patients(57.7%).The rates of vomiting were 92.3%,and grade 3 and grade 4 vomiting were 11.5%.The rates of phlebitis were 15.4%.Conclusion:The NP combination chemotheraphy was effective for metastatic breast cancer and the toxicities were tolerable,It serves as the second line chemotherapy regimen on patient with anthracycline-resistant metastatic breast cancer.
Keywords:Vinorelabine  Cisplatin  Combination chemotherapy  Metastatic breast cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号